A MULTI-MODAL AYURVEDIC INTERVENTION COMBINING PANCHAKARMA, HERBAL MEDICATION, AND CALORIE-RESTRICTED DIET FOR TYPE 2 DIABETES MELLITUS:

Type 2 Diabetes Mellitus (T2DM) is a growing metabolic disorder with rising global prevalence. Conventional pharmacological management, while effective, is often associated with long-term side effects and medication dependence. Ayurveda offers a holistic approach to Prameha (diabetes) through multi-modal interventions. This study evaluates clinical outcomes of an integrated Ayurvedic protocol combining individualized Panchakarma therapies, oral herbal medications, and a structured low-calorie diet in patients with T2DM. This retrospective observational study analyzed data from 29 patients (21 males, 8 females; mean age 45.4 ± 11.3 years) diagnosed with T2DM, treated at the Kharadi branch of a specialised Ayurvedic diabetes management clinic. Patients received one of two Panchakarma-based care plans — CDC-SP therapy (BMI ≥ 23) or CDC-KP therapy (BMI < 23) — comprising Snehan, Swedan, and Basti. All patients were concurrently prescribed oral herbal medications and an 800 kcal Prameha Diet Box. Statistically significant improvements were observed across all measured parameters (p < 0.001). Mean HbA1c decreased from 10.02% to 7.27% (Δ = −2.75%). Mean RBS declined from 226.4 to 141.5 mg/dL (Δ = −85.0). Body weight reduced by 6.2 kg, BMI by 4.32 kg/m², and abdominal girth by 7.1 cm. Systolic blood pressure improved by 12.9 mmHg and diastolic by 4.8 mmHg. The integrated multi-modal Ayurvedic intervention demonstrated clinically meaningful and statistically significant improvements in glycaemic control, anthropometric indices, and blood pressure in T2DM patients. Prospective controlled studies with larger sample sizes are warranted to confirm these findings.

• International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels: IDF; 2024. Available from: https://www.diabetesatlas.org
• GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections to 2050. Lancet, 2023; 402(10397): 203–234. doi:10.1016/S0140-6736(23)01301-6
• Anjana RM, Pradeepa R, Unnikrishnan R, et al. Geographical variation in the prevalence and risk factors of diabetes in India: ICMR-INDIAB national study. Diabetologia, 2023; 66(12): 2252–2263.
• Charaka Samhita. Sutrasthana, Nidanasthana, Chikitsasthana. Varanasi: Chaukhamba Surbharati Prakashan, 2011.
• Revandkar V, Lathi A, Jain A, et al. Role of Aahar and Panchakarma on restoration of euglycemia in T2DM. Int J Res Med Sci., 2023; 11(11):         4077–4081. doi:10.18203/2320-6012.ijrms20233297
• Kshirsagar J, Wankhade V, Nandedkar S, et al. Impact of Ayurvedic Panchakarma along with lifestyle modification in restoring glucose tolerance in T2DM. Int J Basic Clin Pharmacol, 2024; 13(5): 669–672.
• Hegde SV, Adhikari P, Bhuta S, et al. Effect of holistic yoga and Ayurvedic Panchakarma in T2DM: a pilot study. J Complement Integr Med., 2013; 8. doi:10.2202/1553-3840.1365
• Chattopadhyay K, Chandrasekaran AM, Praveen PA, et al. Effectiveness and safety of Ayurvedic medicines in T2DM: systematic review and meta-analysis. Front Med., 2022; 9: 821810. doi:10.3389/fmed.2022.821810 [PMC9213670]
• Laha S, Paul S. Anti-diabetic potential of Gymnema sylvestre: a review. Pharmacognosy J., 2019; 11(6s): 1111–1117.
• Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 2008; 57(5): 712–717. doi:10.1016/j.metabol.2008.01.013
• Fliegerová K, Mahayri TM, Sechovcová H, et al. Diabetes and gut microbiome. Front Microbiol, 2025; 15: 1487024. doi:10.3389/fmicb.2024.1487024
• Lean MEJ, Leslie WS, Barnes AC, et al. Durability of primary care-led weight-management intervention for remission of T2DM: DiRECT trial 2-year results. Lancet Diabetes Endocrinol, 2019; 7(5): 344–355.
• Taheri S, Zaghloul H, Chagoury O, et al. Effect of intensive lifestyle intervention in early T2DM (DIADEM-I): open-label RCT. Lancet Diabetes Endocrinol, 2020; 8(6): 477–489.
• Goldenberg JZ, Day A, Brinkworth GD, et al. Efficacy and safety of low and very low carbohydrate diets for T2DM remission: systematic review and meta-analysis. BMJ., 2021; 372: m4743. doi:10.1136/bmj.m4743
• McInnes N, Smith A, Otto R, et al. Remission of type 2 diabetes with very low-calorie diets — a narrative review. Nutrients, 2021; 13(6): 1890. doi:10.3390/nu13061890
• Mohan V, Unnikrishnan R, Shanthi Rani CS. Are calorie-restricted diets safe in Indians? Indian J Med Res., 2021; 153(3): 321–323.